Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (121-130 of 393) with videos related to

Pageof 40
Sort By:
International Angiology : a Journal of the International Union of Angiology|December 6, 2014
Prevalence of metabolic syndrome in patients with end stage renal disease and relevance of biomarkersJennifer Saluk, Vinod Bansal, Debra Hoppensteadt, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Antithrombotic Agents in the Management of SepsisOmer Iqbal, Mahmut Tobu, Debra Hoppenstead, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 8, 2020
Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its ComponentsFakiha Siddiqui, Debra Hoppensteadt, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 7, 2025
Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 PatientsAlejandro J Gonzalez-Ochoa, Gyozo Szolnoky, Ana G Hernandez-Ibarra, et al.
Journal of Thrombosis and Thrombolysis|January 12, 2012
US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparinsMarc Cohen, Walter P Jeske, Jose C Nicolau, et al.
Journal of Psychiatric Research|March 20, 2018
Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Journal of Psychiatric Research|August 9, 2020
Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 13, 2016
Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant TherapyJeffrey Liles, Jordan Liles, Christopher Wanderling, et al.
Brain, Behavior, and Immunity|January 11, 2020
Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depressionStephen Murata, Michael Murphy, Debra Hoppensteadt, et al.
Immunopharmacology and Immunotoxicology|May 11, 2006
In vivo heparan sulfate treatment alters the immune response of normal and LLC-bearing miceRashid M Rashid, John M Lee, Jawed Fareed, et al.
Pageof 40

Showing results (121-130 of 393) with videos related to

Sort By:
Pageof 40
International Angiology : a Journal of the International Union of Angiology|December 6, 2014
Prevalence of metabolic syndrome in patients with end stage renal disease and relevance of biomarkersJennifer Saluk, Vinod Bansal, Debra Hoppensteadt, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Antithrombotic Agents in the Management of SepsisOmer Iqbal, Mahmut Tobu, Debra Hoppenstead, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 8, 2020
Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its ComponentsFakiha Siddiqui, Debra Hoppensteadt, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 7, 2025
Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 PatientsAlejandro J Gonzalez-Ochoa, Gyozo Szolnoky, Ana G Hernandez-Ibarra, et al.
Journal of Thrombosis and Thrombolysis|January 12, 2012
US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparinsMarc Cohen, Walter P Jeske, Jose C Nicolau, et al.
Journal of Psychiatric Research|March 20, 2018
Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Journal of Psychiatric Research|August 9, 2020
Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 13, 2016
Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant TherapyJeffrey Liles, Jordan Liles, Christopher Wanderling, et al.
Brain, Behavior, and Immunity|January 11, 2020
Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depressionStephen Murata, Michael Murphy, Debra Hoppensteadt, et al.
Immunopharmacology and Immunotoxicology|May 11, 2006
In vivo heparan sulfate treatment alters the immune response of normal and LLC-bearing miceRashid M Rashid, John M Lee, Jawed Fareed, et al.
Pageof 40